Abstract
As the human race is still threatened by prospective avian flu endemics, new motivations and systematic approaches should be placed high on agenda in order to alleviate the potential losses of both human life and local economics. A balance and comprehensive measures between economy and the ecosystem of the endemic regions must also be considered. One of the top priorities in these explorations should be effective therapy for infected patients, including better uses and applications of vaccines and antiviral agents. In order to be better prepared for prospective avian flu epidemics, experimental and theoretical inquiry of therapeutic and technical feasibilities against avian viruses in humans deserve to be priority concerned, and extensive experimental and clinical exploitations of fatal pathogenesis of virus infection in human cells at genetic and cytological levels, are urgently needed. In this review, we address and discuss these important questions and review some important solutions for avian flu in future, including antiviral agents, virus vaccinations, Chinese medicine and genetic treatment of the disease.
Keywords: Avian flu, influenza virus, viral pathogenesis, viral treatment, antiviral agents, viral vaccine, human genome, viral genetic pathogenesis, traditional Chinese medicine, medicinal chemistry, neuraminidase inhibitors
Anti-Infective Agents
Title:Avian Flu; Pathogenesis and Therapy
Volume: 10 Issue: 2
Author(s): Da-Yong Lu, Ting-Ren Lu and Hong-Ying Wu
Affiliation:
Keywords: Avian flu, influenza virus, viral pathogenesis, viral treatment, antiviral agents, viral vaccine, human genome, viral genetic pathogenesis, traditional Chinese medicine, medicinal chemistry, neuraminidase inhibitors
Abstract: As the human race is still threatened by prospective avian flu endemics, new motivations and systematic approaches should be placed high on agenda in order to alleviate the potential losses of both human life and local economics. A balance and comprehensive measures between economy and the ecosystem of the endemic regions must also be considered. One of the top priorities in these explorations should be effective therapy for infected patients, including better uses and applications of vaccines and antiviral agents. In order to be better prepared for prospective avian flu epidemics, experimental and theoretical inquiry of therapeutic and technical feasibilities against avian viruses in humans deserve to be priority concerned, and extensive experimental and clinical exploitations of fatal pathogenesis of virus infection in human cells at genetic and cytological levels, are urgently needed. In this review, we address and discuss these important questions and review some important solutions for avian flu in future, including antiviral agents, virus vaccinations, Chinese medicine and genetic treatment of the disease.
Export Options
About this article
Cite this article as:
Lu Da-Yong, Lu Ting-Ren and Wu Hong-Ying, Avian Flu; Pathogenesis and Therapy, Anti-Infective Agents 2012; 10 (2) . https://dx.doi.org/10.2174/2211362611208020124
DOI https://dx.doi.org/10.2174/2211362611208020124 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preface
Current Pharmaceutical Design Nicotinamide Supplementation Protects Gestational Diabetic Rats by Reducing Oxidative Stress and Enhancing Immune Responses
Current Medicinal Chemistry CD26 Inhibition Enhances Perfusion Recovery in ApoE-/-Mice
Current Vascular Pharmacology Nutraceutical, Antioxidant, Antimicrobial Properties of <i>Pyropia vietnamensis</i> (Tanaka et Pham-Hong Ho) J.E. Sutherl. et Monotilla
Current Bioactive Compounds The Coronin Family and Human Disease
Current Protein & Peptide Science DNA Copy Number Profiles Correlate with Outcome in Colorectal Cancer Patients Treated with Fluoropyrimidine/Antifolate-based Regimens
Current Drug Metabolism Molecular Therapy Intervention Prospects in Prostate Cancer
Current Pharmaceutical Design AZT: An Old Drug with New Perspectives
Current Clinical Pharmacology Pharmacokinetics of Biotech Drugs: Peptides, Proteins and Monoclonal Antibodies
Current Drug Metabolism Investigation of Low Dose Cabazitaxel Potential as Microtubule Stabilizer in Experimental Model of Alzheimer's Disease: Restoring Neuronal Cytoskeleton
Current Alzheimer Research The Radioprotective Potentials of Silymarin/Silibinin Against Radiotherapy- Induced Toxicities: A Systematic Review of Clinical and Experimental Studies
Current Medicinal Chemistry Aspects of Antisense Oligodeoxynucleotide, Ribozyme, DNA Enzyme and RNAi Design
Current Medicinal Chemistry - Central Nervous System Agents Healthy Diet, Grape Phytochemicals, and Vitamin D: Preventing Chronic Inflammation and Keeping Good Microbiota
Endocrine, Metabolic & Immune Disorders - Drug Targets The Connection Between C-Reactive Protein (CRP) and Diabetic Vasculopathy. Focus on Preclinical Findings
Current Diabetes Reviews Rheumatic Manifestations Associated with Inflammatory Bowel Diseases
Current Rheumatology Reviews The Role of the O-GlcNAc Modification in Regulating Eukaryotic Gene Expression
Current Signal Transduction Therapy Therapeutic Proteins and Nanotechnology: Immune Response and Stealth Bioengineered Constructs
Current Drug Metabolism Radiation Protection and Mitigation by Natural Antioxidants and Flavonoids: Implications to Radiotherapy and Radiation Disasters
Current Molecular Pharmacology Synthesis, Computational Analysis, Antimicrobial, Antioxidant, Trypan Blue Exclusion Assay, β-hematin Assay and Anti-inflammatory Studies of some Hydrazones (Part-I)
Current Computer-Aided Drug Design Editorial (Thematic Issue: Microglia - A Therapeutic Target in Neurological Diseases and Disorders)
CNS & Neurological Disorders - Drug Targets